2Buijn LI,Miller TM,Cleveland DW.Unraveling the mechanisms involved in motor neuron degeneration in ALS[J].Annu Rev Neurosci,2004,27:723-749.
3Heath PR,Shaw PJ.Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis[J].Muscle Nerve,2002,26 (4):438-458.
4Volterra A,Trotti D,Tromba C,et al.Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes[J].J Neurosci,1994,14(5):2924-2932.
5Munsat TL,Hollander D.Excitotoxins and amyotrophic lateral sclerosis[J].Therapie,1990,45(3):277-279.
8Kunst CB.Complex genetics of amyotrophic lateral sclerosis[J].Am J Hum Genet,2004,75(6):933-947.
9Siddique T,Figewicz DA,Pericak-vance MA,et al.Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity[J].N Engl J Med,1991,324(20):1381-1384.
10Deng HX,Hentati A,Tainer JA,et al.Amyotrophic lateral sclerosis and structural defects in Cu,Zn.superoxide dismutase[J].Science,1993,261(5124):1047-1051.
6Buijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degenertation in ALS[J]. An nu Rev Neurosci, 2004,27 : 723-749.
7Health PR, Shaw PJ. Updata on the glutamatergic neurotransmitter system and the role of excitotoxieity in amyotrophic lat eral sclerosis[J]. Muscle Nerve,2002,26(4) :438-458.
8Lariviere RC,Julien JP. Functions of intermediate filaments in neuronal development and disease[J]. J Neurobiol, 2004,58 (1):131 -148.
9Rao MV, Nixon RA. Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis= a review [J]. Neurochem Res,2003,28(7) :1 041 -1 047.
10World Federation of Neurology Research on Neurmuscular Disease. El Eseorial World Federation of Neurology criteria for the diagnosis ot amyotrophic lateral sclerosis[J]. J Neuro Sci, 1994,124 (Suppl) : 96-107.
